Guillermo Ruiz‐Irastorza

Active 1996–2025

Also published as
Guillermo Ruiz-Irastorza
120
Papers
26,101
Citations
69
h-index
111
i10-index

Citations

Citations per year for Guillermo Ruiz‐Irastorza1974: 1 citations1983: 1 citations1984: 3 citations1996: 2 citations1997: 1 citations1998: 1 citations1999: 4 citations2000: 5 citations2001: 20 citations2002: 14 citations2003: 24 citations2004: 25 citations2005: 30 citations2006: 33 citations2007: 40 citations2008: 48 citations2009: 46 citations2010: 68 citations2011: 85 citations2012: 92 citations2013: 114 citations2014: 139 citations2015: 116 citations2016: 158 citations2017: 172 citations2018: 174 citations2019: 777 citations2020: 1,002 citations2021: 951 citations2022: 791 citations2023: 501 citations2024: 1,090 citations2025: 422 citations2026: 7 citations1975–1982: no citations, so these years are not shown1985–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,557 citing papers, 17% of this breakdownChina: 711 citing papers, 7.8% of this breakdownUnited Kingdom: 642 citing papers, 7% of this breakdownItaly: 636 citing papers, 6.9% of this breakdownCanada: 418 citing papers, 4.6% of this breakdownSpain: 406 citing papers, 4.4% of this breakdownFrance: 395 citing papers, 4.3% of this breakdownGermany: 342 citing papers, 3.7% of this breakdownSweden: 276 citing papers, 3% of this breakdownNetherlands: 274 citing papers, 3% of this breakdownJapan: 230 citing papers, 2.5% of this breakdownAustralia: 207 citing papers, 2.3% of this breakdown
0%17%Other 33.5%

Fields

  • Medicine86.1%
  • Immunology and Microbiology7.4%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Neuroscience0.8%
  • Environmental Science0.2%
  • Health Professions0.1%
  • Other0.8%

Topics

  • Systemic Lupus Erythematosus Research22%
  • Rheumatoid Arthritis Research and Therapies5.6%
  • Systemic Sclerosis and Related Diseases3.5%
  • T-cell and B-cell Immunology3.3%
  • Pregnancy and Medication Impact3.1%
  • Monoclonal and Polyclonal Antibodies Research2.8%
  • Other59.7%

Coauthors

All papers

Open in search
  1. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder - Arthritis & Rheumatism 2012 cited by 5,295

  2. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara K. Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa Fernández, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Thomas Dörner, Sindhu R. Johnson - Annals of the Rheumatic Diseases 2019 cited by 2,515

  3. Systemic lupus erythematosus

    Authors: , , , , , , , - Nature Reviews Disease Primers 2016 cited by 1,355

  4. EULAR recommendations for the management of antiphospholipid syndrome in adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 1,205

  5. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 1,058

  6. The frequency and outcome of lupus nephritis: results from an international inception cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asad Zoma, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, S. Sam Lim, Thomas Stoll, Murat İnanç, Kenneth Kalunian, Diane L. Kamen, Peter J. Maddison, Christine Peschken, Søren Jacobsen, Anca Askanase, Chris Theriault, Kara Thompson, Vernon T. Farewell - Lara D. Veeken 2015 cited by 632

  7. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meggan Mackay, Manuel Ramos‐Casals, Ronald van Vollenhoven, Kenneth Kalunian, Guillermo Ruiz‐Irastorza, Sam Lim, Diane L. Kamen, Christine Peschken, Murat İnanç, Murray B. Urowitz - Annals of the Rheumatic Diseases 2014 cited by 566

  8. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

    Authors: , , , - Annals of the Rheumatic Diseases 2008 cited by 982

  9. Antiphospholipid syndrome

    Authors: , , , , , , , , , - Nature Reviews Disease Primers 2018 cited by 352

  10. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guillermo Ruiz‐Irastorza, Sam Lim, Murat İnanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Jill P. Buyon, David Sontag, Karen H. Costenbader - Annals of the Rheumatic Diseases 2023 cited by 81

  11. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

    Authors: , , , , , , , , , , , , , , - Journal of Translational Medicine 2022 cited by 86

  12. Antiphospholipid syndrome

    Authors: , , , - The Lancet 2010 cited by 816

  13. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Ramos‐Casals, Kristján Steinsson, Asad Zoma, Anca Askanase, Munther A. Khamashta, Ian N Bruce, Murat İnanç, Michał Abrahamowicz, Sasha Bernatsky - Annals of the Rheumatic Diseases 2021 cited by 98

  14. Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2023 cited by 42

  15. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus

    Authors: , , , , , , , - Lupus 2006 cited by 415

  16. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Peschken, Diane L. Kamen, Anca Askanase, Bernardo A. Pons‐Estel, Graciela S. Alarcón - Annals of the Rheumatic Diseases 2022 cited by 56

  17. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Βertsias, Ilaria Bini, Anca Bobîrcă, Ware Branch, Antonio Brucato, Irene E. M. Bultink, S. Capela, Irene Cecchi, Ricard Cervera, Cecilia Beatrice Chighizola, Claudia Cobilinschi, María José Cuadrado, Dzifa Dey, Oseme Etomi, Gerard Espinosa, Julia Flint, João-Eurico Fonseca, Ruth Fritsch‐Stork, Maria Gerosa, Bente Glintborg, Carina Gøtestam Skorpen, Bethan Goulden, Christine Graversgaard, Iva Gunnarsson, Latika Gupta, Merete Lund Hetland, Kenneth Hodson, Beverley J. Hunt, David Isenberg, Søren Jacobsen, Munther A. Khamashta, Roger A. Levy, Louise Linde, Jacob Alexander Lykke, Yvette Meißner, Louise Moore, Eric F. Morand, Sandra Navarra, Daniela Opriș-Belinski, Monika Østensen, Hiroki Ozawa, Luis Fernando Pérez-García, Michelle Petri, Guillermo Pons‐Estel, Massimo Radin, Luigi Raio, Amihai Rottenstreich, Guillermo Ruiz‐Irastorza, Slađana Rumpl Tunjić, Marite Rygg, Savino Sciascia, Anja Strangfeld, Elisabet Svenungsson, Maria G. Tektonidou, Anne Troldborg, Évelyne Vinet, Jelena Vojinović, Anne Voss, Marianne Wallenius, Laura Andréoli - The Lancet Rheumatology 2023 cited by 34

  18. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs

    Authors: , - Lara D. Veeken 2020 cited by 141

  19. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Peschken, Diane L. Kamen, Anca Askanase, Vernon T. Farewell - Annals of the Rheumatic Diseases 2020 cited by 77

  20. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Peschken, Bernardo A. Pons‐Estel, Anisur Rahman, Rosalind Ramsey‐Goldman, John A. Reynolds, Juanita Romero‐Díaz, Guillermo Ruiz‐Irastorza, Jorge Sánchez‐Guerrero, Elisabet Svenungsson, Murray B. Urowitz, Évelyne Vinet, Ronald van Vollenhoven, Alexandre E. Voskuyl, Daniel J. Wallace, Michelle Petri, Susan Manzi, Ann E. Clarke, Mike W.‐L. Cheung, Vernon T. Farewell, Graciela S. Alarcón - Lupus Science & Medicine 2021 cited by 91

  21. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franco Franceschini, Corrado Campochiaro, Alessandro Tomelleri, Alicia Callisto, Mark Beecher, Sara Bindoli, Chiara Baggio, Verónica Gómez‐Caverzaschi, Laura Pelegrín, Adriana Soto-Peleteiro, Alessandra Milanesi, İ. Vasi, Alberto Cauli, Isabele Parente de Brito Antonelli, Florenzo Iannone, Riccardo Bixio, Francesca Della Casa, Ilaria Mormile, Carmelo Gurnari, Alessia Fiorenza, Germán Mejía‐Salgado, Perla Ayumi Kawakami‐Campos, Gaafar Ragab, Francesco Ciccia, Piero Ruscitti, Monica Bocchia, Alberto Balistreri, Gian Marco Tosi, Bruno Frediani, Luca Cantarini, Claudia Fabiani - Seminars in Arthritis and Rheumatism 2024 cited by 35

  22. High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus

    Authors: , , , - Archives of Internal Medicine 2004 cited by 237

  23. Correction: Antiphospholipid syndrome

    Authors: , , , , , , , , , - Nature Reviews Disease Primers 2018 cited by 169

  24. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus

    Authors: , , , , , - Lara D. Veeken 2014 cited by 221